- Home
- CCEL vs IINN Comparison
CCEL vs IINN Comparison
Compare CCEL & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- IINN
- Stock Information
- Founded
- CCEL 1989
- IINN 2018
- Country
- CCEL United States
- IINN Israel
- Employees
- CCEL N/A
- IINN N/A
- Industry
- CCEL Managed Health Care
- IINN Medical/Dental Instruments
- Sector
- CCEL Health Care
- IINN Health Care
- Exchange
- CCEL Nasdaq
- IINN Nasdaq
- Market Cap
- CCEL 36.7M
- IINN 34.1M
- IPO Year
- CCEL 1997
- IINN 2021
- Fundamental
- Price
- CCEL $4.72
- IINN $1.15
- Analyst Decision
- CCEL Strong Buy
- IINN Strong Buy
- Analyst Count
- CCEL 1
- IINN 1
- Target Price
- CCEL $8.50
- IINN $2.00
- AVG Volume (30 Days)
- CCEL 17.6K
- IINN 1.5M
- Earning Date
- CCEL 10-14-2025
- IINN 09-12-2025
- Dividend Yield
- CCEL 12.77%
- IINN N/A
- EPS Growth
- CCEL N/A
- IINN N/A
- EPS
- CCEL N/A
- IINN N/A
- Revenue
- CCEL $31,988,783.00
- IINN N/A
- Revenue This Year
- CCEL $1.75
- IINN N/A
- Revenue Next Year
- CCEL N/A
- IINN $2,050.00
- P/E Ratio
- CCEL N/A
- IINN N/A
- Revenue Growth
- CCEL 1.10
- IINN N/A
- 52 Week Low
- CCEL $4.09
- IINN $0.40
- 52 Week High
- CCEL $9.43
- IINN $1.65
- Technical
- Relative Strength Index (RSI)
- CCEL 51.06
- IINN 44.81
- Support Level
- CCEL $4.21
- IINN $1.11
- Resistance Level
- CCEL $4.82
- IINN $1.19
- Average True Range (ATR)
- CCEL 0.26
- IINN 0.12
- MACD
- CCEL 0.03
- IINN -0.02
- Stochastic Oscillator
- CCEL 84.00
- IINN 14.63
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.